SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (167)5/6/1997 10:30:00 AM
From: DZOO   of 834
 
I agree for the most part. The big question in my mind is this: Will TXB have to do more clinicals in order to use their product with Retavase or can they qualify through some similarities. I've done due diligence on TXB and cannot find any mention of Retavase. I'm not a med pro but have partners that are (not in this particular discipline) and that is their question. I guess the importance is more analytical in nature. TXB has a good product (no doubt in my mind) but clinicals burn cash and I don't have the cost of more clinicals modeled into the numbers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News